BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

766 related articles for article (PubMed ID: 31680319)

  • 21. circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC).
    Tang YF; Liu ZH; Zhang LY; Shi SH; Xu S; Ma JA; Hu CH; Zou FW
    Mol Cancer; 2024 May; 23(1):91. PubMed ID: 38715012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR-1299-mediated IRF7 activation.
    Lin L; Cai J
    J Cell Biochem; 2020 Nov; 121(11):4377-4385. PubMed ID: 31904147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular RNA hsa_circ_0002360 promotes non-small cell lung cancer progression through upregulating matrix metalloproteinase 16 and sponging multiple micorRNAs.
    Zhang Y; Zeng S; Wang T
    Bioengineered; 2021 Dec; 12(2):12767-12777. PubMed ID: 34747300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
    Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT
    Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of circular RNA hsa_circ_0001038 promotes cervical cancer cell progression by acting as a ceRNA for miR-337-3p to regulate cyclin-M3 and metastasis-associated in colon cancer 1 expression.
    Wang Y; Wang L; Wang W; Guo X
    Gene; 2020 Apr; 733():144273. PubMed ID: 31809842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circ_0072088 promotes the development of non-small cell lung cancer via the miR-377-5p/NOVA2 axis.
    Tan Z; Cao F; Jia B; Xia L
    Thorac Cancer; 2020 Aug; 11(8):2224-2236. PubMed ID: 32524752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNA circ_0001649 acts as a prognostic biomarker and inhibits NSCLC progression via sponging miR-331-3p and miR-338-5p.
    Liu T; Song Z; Gai Y
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1503-1509. PubMed ID: 30029881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA circ_0074026 indicates unfavorable prognosis for patients with glioma and facilitates oncogenesis of tumor cells by targeting miR-1304 to modulate ERBB4 expression.
    Chen M; Liu X; Xie P; Wang P; Liu M; Zhan Y; Wang H; Feng Y; Li Y
    J Cell Physiol; 2020 May; 235(5):4688-4697. PubMed ID: 31643077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNA circ_0010235 sponges miR-338-3p to play oncogenic role in proliferation, migration and invasion of non-small-cell lung cancer cells through modulating KIF2A.
    Zhu Y; Ma C; Lv A; Kou C
    Ann Med; 2021 Dec; 53(1):693-706. PubMed ID: 34024242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circular RNA hsa_circ_0102231 sponges miR-145 to promote non-small cell lung cancer cell proliferation by up-regulating the expression of RBBP4.
    Cao X; Li F; Shao J; Lv J; Chang A; Dong W; Zhu F
    J Biochem; 2021 Feb; 169(1):65-73. PubMed ID: 33084863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
    Zhang C; Li Y; Zhao W; Liu G; Yang Q
    Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hsa_circ_0069244 acts as the sponge of miR-346 to inhibit non-small cell lung cancer progression by regulating XPC expression.
    Shi J; Wang H; Feng W; Huang S; An J; Wang L; Jiang J
    Hum Cell; 2021 Sep; 34(5):1490-1503. PubMed ID: 34228324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circular RNA circ-RAD23B promotes cell growth and invasion by miR-593-3p/CCND2 and miR-653-5p/TIAM1 pathways in non-small cell lung cancer.
    Han W; Wang L; Zhang L; Wang Y; Li Y
    Biochem Biophys Res Commun; 2019 Mar; 510(3):462-466. PubMed ID: 30722989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. circRNA hsa_circ_0005909 Predicts Poor Prognosis and Promotes the Growth, Metastasis, and Drug Resistance of Non-Small-Cell Lung Cancer via the miRNA-338-3p/SOX4 Pathway.
    Song HM; Meng D; Wang JP; Zhang XY
    Dis Markers; 2021; 2021():8388512. PubMed ID: 34413915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CircRNA circ_0008037 facilitates tumor growth and the Warburg effect via upregulating NUCKS1 by binding to miR-433-3p in non-small cell lung cancer.
    Yu J; Zhang H; Zhao C; Li G; Zhang Y; Sun Y
    Thorac Cancer; 2022 Jan; 13(2):162-172. PubMed ID: 34850570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpressed circ_0029426 in glioblastoma forecasts unfavorable prognosis and promotes cell progression by sponging miR-197.
    Zhang G; Sun W; Zhu L; Feng Y; Wu L; Li T
    J Cell Biochem; 2019 Jun; 120(6):10295-10302. PubMed ID: 30548670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
    Zheng Y; Duan L; Yang Y; Luo D; Yan B
    Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of Circular RNA Hsa_circ_0109320 Attenuates Non-Small Cell Lung Cancer Progression via MiR-595/E2F7 Axis.
    Bai Q; Li L; Chen F; Zhu J; Cao L; Yang Y; Zhong F
    Med Sci Monit; 2020 Jun; 26():e921200. PubMed ID: 32508344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
    Shao N; Song L; Sun X
    Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
    Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.